Utama › Penyakit Hati Steatotik › California › San Diego
Kajian klinikal Penyakit Hati Steatotik di San Diego, CA
14 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar San Diego (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Coronado · 2 mi jauh
- 89bio Clinical Study Site, La Jolla · 11 mi jauh
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Coronado · 2 mi jauh
- 89bio Clinical Study Site, La Jolla · 11 mi jauh
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Mengambil pesertaFasa 2
- Southern California Research Center, Coronado · 2 mi jauh
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Mengambil pesertaFasa 2
- University of California San Diego NAFLD Research Center, La Jolla · 11 mi jauh
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Mengambil pesertaFasa 2
- Southern California Research Center, Coronado · 2 mi jauh
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mengambil pesertaFasa 3
- Medical Associates Research Group, San Diego
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi jauh
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Mengambil pesertaFasa 3
- Akero Clinical Study Site, Coronado · 2 mi jauh
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, San Diego
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 2
- UCSD Medical Center, La Jolla · 11 mi jauh
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Mengambil pesertaFasa 2
- GSK Investigational Site, Coronado · 2 mi jauh
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, San Diego
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Mengambil pesertaKajian pemerhatian
- University of California San Diego, La Jolla · 11 mi jauh
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
Mengambil pesertaKajian pemerhatian
- University of California San Diego, La Jolla · 11 mi jauh
Implementing Food Referrals for Equity and Sustained Health
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- Rady Children's Hospital San Diego, San Diego
Kajian Penyakit Hati Steatotik di bandar lain
- San Antonio, TX17 kajian
- New York City, NY16 kajian
- Miami, FL16 kajian
- Austin, TX13 kajian
- Houston, TX13 kajian
- Richmond, VA12 kajian
- Tucson, AZ10 kajian
- Chandler, AZ10 kajian
- Hialeah, FL9 kajian
- Dallas, TX9 kajian
- Orlando, FL9 kajian
- St. Louis, MO9 kajian
Kajian lain di San Diego
- Kanser Paru-paru Bukan Sel Kecil48 kajian
- Kanser Payudara41 kajian
- Kanser (semua jenis)32 kajian
- Kanser Prostat31 kajian
- Kanser Metastatik30 kajian
- Kanser Kolorektal25 kajian
- Kanser Ovari24 kajian
- Kanser Pankreas24 kajian
- Kanser Paru-paru23 kajian
- Obesiti23 kajian
- Kegagalan Jantung23 kajian
- Depresi21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.